Mirum Pharmaceuticals, Inc.
MIRM나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
5건
최근 2026.10.27
90일 내부자 순매수
-13억 6,933만원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 11건
- US미국주요사항·수시공시중요도 낮음7일 전8-K · Current report (Items 8.01)
Mirum Pharmaceuticals, Inc.MIRM
8-K · 2026.10.27 05:47 KST
- US미국임원·주요주주 소유중요도 낮음2026.10.194 · Statement of changes in beneficial ownership
Mirum Pharmaceuticals, Inc.MIRM
Form 4 · 2026.10.19
- US미국임원·주요주주 소유중요도 낮음2026.10.144 · Statement of changes in beneficial ownership
Mirum Pharmaceuticals, Inc.MIRM
Form 4 · 2026.10.14
- US미국주요사항·수시공시중요도 낮음2026.10.138-K · Current report (Items 8.01)
Mirum Pharmaceuticals, Inc.MIRM
8-K · 2026.10.13 21:09 KST
- US미국임원·주요주주 소유중요도 낮음2026.10.064 · Statement of changes in beneficial ownership
Mirum Pharmaceuticals, Inc.MIRM
Form 4 · 2026.10.06
- US미국주요사항·수시공시중요도 낮음2026.09.288-K · Current report (Items 8.01)
Mirum Pharmaceuticals, Inc.MIRM
8-K · 2026.09.28 21:02 KST
- US미국임원·주요주주 소유중요도 낮음2026.09.223 · Initial statement of beneficial ownership
Mirum Pharmaceuticals, Inc.MIRM
Form 3 · 2026.09.22
- US미국임원·주요주주 소유중요도 높음2026.09.154 · Statement of changes in beneficial ownership
Mirum Pharmaceuticals, Inc.MIRM
Form 4 · 2026.09.15
- US미국지배구조·주총중요도 보통2026.09.088-K · Current report (Items 5.02)
Mirum Pharmaceuticals, Inc.MIRM
8-K · 2026.09.08 21:34 KST
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Mirum Pharmaceuticals, Inc.MIRM
Form 4 · 2026.09.03